Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 48 Records) |
| Query Trace: Breast Neoplasms and HLA-B[original query] |
|---|
| Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: a meta-analysis and systematic review. Human immunology 2014 Aug 75 (8): 827-32. Ge Yu-Zheng, Ge Qian, Li Ming-Hao, Shi Guo-Mei, Xu Xiao, Xu Lu-Wei, Xu Zheng, Lu Tian-Ze, Wu Ran, Zhou Liu-Hua, Wu Jian-Ping, Liang Kai, Dou Quan-Liang, Zhu Jia-Geng, Li Wen-Cheng, Jia Rui-Pe |
| Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients. PloS one 2014 9 (5): e98284. Jeong Seri, Park Seho, Park Byeong-Woo, Park Younhee, Kwon Oh-Joong, Kim Hyon-S |
| Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Aug 32 (22): 2296-303. Schaid Daniel J, Spraggs Colin F, McDonnell Shannon K, Parham Laura R, Cox Charles J, Ejlertsen Bent, Finkelstein Dianne M, Rappold Erica, Curran Joan, Cardon Lon R, Goss Paul |
| 14-bp Insertion/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran. Asian Pacific journal of cancer prevention : APJCP 2015 16 (14): 6155-8. Haghi Mehdi, Hosseinpour Feizi Mohammad Ali, Sadeghizadeh Majid, Lotfi Abbas Sahebghad |
| [HLA-E gene polymorphisms and plasma soluble HLA-E levels and their relationship with genetic susceptibility to breast cancer]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 2015 Apr 31 (4): 524-7. Zhou Yan, Wu Zhencun, Tang Yuhong, Jia Tianj |
| Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study. Molecular genetics and genomics : MGG 2015 Aug 290 (4): 1235-45. Li Tao, Huang Haohai, Liao Dan, Ling Huahuang, Su Bingguang, Cai Mao |
| Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer. Immunogenetics 2016 Sep . Alomar Suliman Y, Alkhuriji Afrah, Trayhyrn Paul, Alhetheel Abdulkarim, Al-Jurayyan Abdullah, Mansour Lamj |
| Immune DNA signature of T-cell infiltration in breast tumor exomes. Scientific reports 2016 6 30064. Levy Eric, Marty Rachel, Gárate Calderón Valentina, Woo Brian, Dow Michelle, Armisen Ricardo, Carter Hannah, Harismendy Olivi |
| KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors. Frontiers in immunology 2016 7 561. Morales-Estevez Cristina, De la Haba-Rodriguez Juan, Manzanares-Martin Barbara, Porras-Quintela Ignacio, Rodriguez-Ariza Antonio, Moreno-Vega Alberto, Ortiz-Morales Maria J, Gomez-España Maria A, Cano-Osuna Maria T, Lopez-Gonzalez Javier, Chia-Delgado Beatriz, Gonzalez-Fernandez Rafael, Aranda-Aguilar Enriq |
| Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population. Immunologic research 2016 08 64 (4): 961-8. Zidi Inès, Dziri Olfa, Zidi Nour, Sebai Refaat, Boujelebene Nadia, Ben Hassine Amna, Ben Yahia Hamza, Laaribi Ahmed Baligh, Babay Wafa, Rifi Hela, Mezlini Amel, Chelbi Hane |
| Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. The pharmacogenomics journal 2017 8 18 (3): 480-486. Spraggs C F, Parham L R, Briley L P, Warren L, Williams L S, Fraser D J, Jiang Z, Aziz Z, Ahmed S, Demetriou G, Mehta A, Jackson N, Byrne J, Andersson M, Toi M, Harris L, Gralow J, Zujewski J A, Crescenzo R, Armour A, Perez E, Piccart |
| Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients. Oncology research 2017 Mar . Todorova Valentina K, Makhoul Issam, Dhakal Ishwori, Wei Jeanne, Stone Annjanette, Carter Weleetka, Owen Aaron, Klimberg V Suzan |
| The Impact of HLA-G 3'UTR Polymorphisms in Breast Cancer in a Tunisian Population. Immunological investigations 2019 Apr 1-12. Ouni Nesrine, Chaaben Arij Ben, Kablouti Ghalia, Ayari Fayza, Douik Hayet, Abaza Hajer, Gara Sonia, Elgaaied-Benammar Amel, Guemira Fethi, Tamouza Ry |
| Association of HLA-G 3'UTR 14-bp Ins/Del polymorphism with breast cancer among South Indian women. Journal of clinical pathology 2019 Dec . Kadiam Sony, Ramasamy Thirunavukkarasu, Ramakrishnan Revathi, Mariakuttikan Jayalaksh |
| Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania. Asian Pacific journal of cancer prevention : APJCP 2019 Nov 20 (11): 3465-3472. Adolf Ismael Chatita, Akan Gokce, Mselle Teddy F, Dharsee Nazima, Namkinga Lucy A, Atalar Fatmah |
| Breast Cancer Is Associated with Increased HLA-DRB1*11:01 and HLA-DRB1*10:01 Allele Frequency in a Population of Patients from Central Italy. Immunological investigations 2020 3 49 (5): 489-497. Aureli Anna, Canossi Angelica, Del Beato Tiziana, Buonomo Oreste, Rossi Piero, Roselli Mario, Papola Franco, Marziani Beatrice, Sconocchia Giusep |
| Certain haplotypes of the 3'-UTR region of the HLA-G gene are linked to breast cancer. British journal of biomedical science 2020 11 78 (2): 87-91. Haghi M, Ranjbar M, Karari K, Samadi-Miandoab S, Eftekhari A, Hosseinpour-Feizi M |
| Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis. Frontiers in molecular biosciences 2020 11 7 569414. Song Jukun, Han Jing, Liu Feng, Chen Xianlin, Qian Shenqi, Wang Yadong, Jia Zhenyu, Duan Xiaofeng, Zhang Xiangyan, Zhu Jiang |
| Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk. Scientific reports 2021 Apr 11 (1): 7932. Ashouri Elham, Rajalingam Karan, Barani Shaghik, Farjadian Shirin, Ghaderi Abbas, Rajalingam Ra |
| Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis. Medicine 2021 Mar 100 (12): e25078. Liu Linlin, Sun Xu, Yuan Chenxi, Liu Huaim |
| The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer. Cancer research and treatment 2021 12 54 (4): 1111-1120. Song In Hye, Kim Young-Ae, Heo Sun-Hee, Bang Won Seon, Park Hye Seon, Choi Yeon Ho, Lee Heejae, Seo Jeong-Han, Cho Youngjin, Jung Sung Wook, Kim Hee Jeong, Ahn Sei Hyun, Lee Hee Jin, Gong Gyungy |
| Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives. Mutation research. Reviews in mutation research 2021 12 788 108391. Cura Yasmin, Pérez Ramírez Cristina, Sánchez Martín Almudena, Martínez Martínez Fernando, Calleja Hernández Miguel Ángel, Ramírez Tortosa María Del Carmen, Jiménez Morales Alber |
| Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso. Open life sciences 2021 10 16 (1): 1101-1110. Zouré Abdou Azaque, Amegnona Lanyo Jospin, Zongo Nayi, Kiendrebeogo Isabelle Touwendpoulimdé, Sorgho Pegdwendé Abel, Zongo Fabienne Ingrid, Yonli Albert Théophane, Sombié Herman Karim, Bambara Aboubacar Hierrhum, Sawadogo Alexis Yobi, Ouedraogo Marie N L, Traoré Lassina, Zongo Sidnooma Véronique, Lallogo Doriane Tatiana, Bazié Bapio Valery Jean Télesphore Elvira, Zohoncon Théodora M, Dijgma Florencia W, Simpore Jacqu |
| Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene-gene and gene-lifestyle interaction. Scientific reports 2021 Jan 11 (1): 1058. Jung Su Yon, Papp Jeanette C, Sobel Eric M, Pellegrini Matteo, Yu Herbert, Zhang Zuo-Fe |
| 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis. Immunology letters 2022 Jun 248 78-89. Tizaoui Kalthoum, Jalouli Maroua, Ouzari Hadda-Imene, Harrath Abdel Halim, Rizzo Roberta, Boujelbene Nadia, Zidi In |
| Relevance of the MHC region for breast cancer susceptibility in Asians. Breast cancer (Tokyo, Japan) 2022 May . Ho Peh Joo, Khng Alexis Jiaying, Tan Benita Kiat-Tee, Tan Ern Yu, Tan Su-Ming, Tan Veronique Kiak Mien, Lim Geok Hoon, Aronson Kristan J, Chan Tsun L, Choi Ji-Yeob, Dennis Joe, Ho Weang-Kee, Hou Ming-Feng, Ito Hidemi, Iwasaki Motoki, John Esther M, Kang Daehee, Kim Sung-Won, Kurian Allison W, Kwong Ava, Lophatananon Artitaya, Matsuo Keitaro, Mohd-Taib Nur Aishah, Muir Kenneth, Murphy Rachel A, Park Sue K, Shen Chen-Yang, Shu Xiao-Ou, Teo Soo Hwang, Wang Qin, Yamaji Taiki, Zheng Wei, Bolla Manjeet K, Dunning Alison M, Easton Douglas F, Pharoah Paul D P, Hartman Mikael, Li Jingm |
| Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes. Journal of translational medicine 2022 12 20 (1): 623. Nachmanson Daniela, Pagadala Meghana, Steward Joseph, Cheung Callie, Bruce Lauryn Keeler, Lee Nicole Q, O'Keefe Thomas J, Lin Grace Y, Hasteh Farnaz, Morris Gerald P, Carter Hannah, Harismendy Olivi |
| Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population. The journal of gene medicine 2022 11 25 (2): e3463. Chen Jiaping, Zhou Jing, Jiang Yue, Wang Yuzhuo, Chen Congcong, Jiang Tao, Du Jiang |
| KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. Frontiers in immunology 2022 1 12 791958. Muraro Elena, De Zorzi Mariangela, Miolo Gianmaria, Lombardi Davide, Scalone Simona, Spazzapan Simon, Massarut Samuele, Perin Tiziana, Dolcetti Riccardo, Steffan Agostino, De Re Val |
| Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment. Breast cancer research and treatment 2023 4 . Chi Xu, Yahui Wang, Yuanyuan Hong, Ru Yao, Lijia Wu, Xi Shen, Yang Qu, Zhuo Zhang, Wei Zhu, Ying Yang, Weizhi Chen, Yidong Zhou, Zhiyong Lia |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: